drugset / Trial / NCT02871882

Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus

NCT02871882 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

To study the effect of an ileocolonic formulation of ox bile extract on insulin sensitivity, postprandial glycemia and incretin levels, gastric emptying, body weight and fasting serum FGF-19 (fibroblast growth factor) levels in overweight or obese type 2 diabetic subjects on therapy with DPP4 (dipeptidyl peptidase-4) inhibitors (e.g. sitagliptin) alone or in combination with metformin.

Timeline

Start
2016-09-15
Primary completion
2017-10-18
Completion
2017-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Conjugated bile acids sodium Unknown 500 mg Oral